# Emergent BioSolutions Inc.: Form 8-K, filed Feb 14, 2018

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2018-02-14
- Accepted by EDGAR: Feb 14, 2018, 17:06 ET
- Period: 2018-02-13
- Accession: 0001367644-18-000008
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764418000008/form8-k-01122018.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764418000008/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764418000008/form8-k-01122018.htm

Filed Feb 14, 2018.
Source: SEC EDGAR, the filing index for accession 0001367644-18-000008. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
